503. Clonal Hematopoiesis, Aging and Inflammation: Poster I

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Clonal Hematopoiesis in Whole-Blood and Cell-Free DNA of Ovarian Cancer Patients Undergoing PARP-Inhibitor Treatment: An Exploratory Analysis of the E

Machine Learning for Identification of High-Risk Clonal Haematopoiesis Using Blood Count Data

Exploring Clonal Hematopoiesis in Chronic Graft Versus Host Disease Patients: A Comprehensive Study

DNMT3A-Mutated Stem and Progenitor Cells Contribute to Altered T Cell Activation in Clonal Hematopoiesis

1-Year Data Analysis from a Cancer Center Molecular Tumor Board Dedicated to Clonal Hematopoiesis

Mechanisms of Aging Vary with Developmental Stages in the Human Hematopoietic Trajectory

TNFa-Driven Interplay between Hematopoietic Stem Cells and Antigen-Specific Cytotoxic T Cells

A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression o